tradingkey.logo

Dynavax rises on debt refinancing plan

ReutersMar 6, 2025 3:11 PM

Shares of vaccine maker Dynavax Technologies DVAX.O rise 1.8% to $14.26

DVAX announces refinancing plan that extends the maturity of most of existing debt by four years

Will issue $225 million of new convertible notes due in 2030

New notes to replace about $185 million of existing convertible notes due in 2026, and an additional $40 million of new money will be raised

New debt has a lower interest rate of 2% and a conversion price of $18.21/share; 30% premium to the stock's last close

Co is buying back $8 mln of its own stock to keep the number of shares outstanding neutral

DVAX to get $46.5 million from unwinding derivatives to partially offset the premium paid for the existing notes

Co has 124.10 mln shares outstanding with a market cap of $1.7 bln - LSEG data

DVAX fell 11.2% in 2024

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI